Osler Diagnostics Limited
Private Limited Company · Oxford
ActiveUnited KingdomIncorporated 2016Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2020-12-31
IXBRL · 378 source facts · 31 selected values
Not assessedlegacy record
Accounts to 2020-12-31
IXBRL · 378 source facts · 31 selected values
Not assessed
legacy record
- Reporting period
- 2020-01-01 to 2020-12-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 277
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- FRS-102-2019-01-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0090_10001467_20201231
- Source archive
- Accounts_Monthly_Data-May2021.zip
Registered details
10001467- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2016-02-11
- Jurisdiction
- —
- Registered office
- KING CHARLES HOUSE, PARK END STREET, OXFORD, OX1 1JD, ENGLAND
Classification
1 SIC codes23112
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
1 SH01-derived rounds2022-11-08
£71,046,173 raised
£284,188,379 estimated post-money
Research and innovation
6 matched grantsHigh-sensitivity, low-cost point of care testing for infection to combat antimicrobial resistance by reducing over-prescription of antibioticsLead
Innovate UK · Collaborative R&D · 2022-04-01 – 2024-03-31
£597,097
awarded
High sensitivity multiplex testing with a novel cardiac biomarker for rapid triage of acute chest pain patients enabling healthcare efficiencies and improved patient outcomesLead
Innovate UK · Feasibility Studies · 2021-10-01 – 2022-12-31
£299,990
awarded
An innovative universal point-of-care diagnostic platform delivering cost-effective, high-sensitivity and multiplexed testing targeting rapid detection and diagnosis of sepsisLead
Innovate UK · Study · 2020-06-01 – 2021-11-30
£299,935
awarded
Developing an On-Chip Reagentless Cancer screenEPSRC · Studentship · 2019-04-30 – 2023-12-31 · with 1 other participant£0whole project
Developing an On-Chip Reagentless Cancer screen
EPSRC · Studentship · 2019-04-30 – 2023-12-31 · with 1 other participant
£0
whole project
University Of OxfordleadOsler Diagnostics Ltd
Development of a small, low-cost, accurate and rapid Point-of-Care diagnostic platform, with primary application to critical cardiovascular markersLeadInnovate UK · Collaborative R&D · 2018-11-01 – 2020-01-31 · with 2 other participants£701,384awarded
Development of a small, low-cost, accurate and rapid Point-of-Care diagnostic platform, with primary application to critical cardiovascular markersLead
Innovate UK · Collaborative R&D · 2018-11-01 – 2020-01-31 · with 2 other participants
£701,384
awarded
Osler Diagnostics Limitedlead£701,384
University of Oxford£201,646
Oxford University Hospitals NHS Foundation Trust£52,126
Oxford Impedance Diagnostics - operationalising a disruptive Point of Care platformLead
Innovate UK · Feasibility Studies · 2018-01-01 – 2018-06-30
£104,113
awarded